2014 annual financial data
Karyopharm Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -22,465.94%.
Operating income was -75,846,000 USD and net income was -75,777,000 USD.
Operating cash flow was -51,447,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 229,000 USD
- Operating income
- -75,846,000 USD
- Net income
- -75,777,000 USD
- Operating cash flow
- -51,447,000 USD